59
Participants
Start Date
November 30, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
PF-04965842
Subjects will receive 200 mg PF 04965842 twice daily for 4 weeks
PF-04965842
Subjects will receive 400 mg PF 04965842 daily for 4 weeks
PF-04965842
Subjects will receive 200 mg PF 04965842 daily for 4 weeks
Placebo
Subjects will receive placebo for 4 weeks
Mount Sinai Medical Center, New York
Virginia Clinical Research, Norfolk
Dermatology Consulting Services, High Point
Duke University Medical Center - Shipment Only, Durham
Duke University Medical Center, Durham
Advanced Medical Research, Inc, Atlanta
Columbus Dermatology, P.C., Columbus
Columbus Regional Research Institute, Columbus
Park Avenue Dermatology, PA, Orange Park
Leavitt Medical Associates of Florida d/b/a Ameriderm Research, Ormond Beach
North Florida Dermatology Associates, PA, Jacksonville
Total Skin and Beauty Dermatology Center, PC, Birmingham
International Dermatology Research, Inc., Miami
Olympian Clinical Research, Clearwater
Westcoast Radiology Services, Clearwater
DS Research, Louisville
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Dawes Fretzin Dermatology Group, LLC, Indianapolis
Health Concepts, Rapid City
Dundee Dermatology, West Dundee
Shondra L Smith, MD, Lake Charles
Northwest Arkansas Clinical Trials Center, PLLC/Hull Dermatology, PA, Rogers
Lynn Health Science Institute, Oklahoma City
Dermatology Treatment & Research Center, PA, Dallas
Arlington Research Center, Inc., Arlington
Center for Clinical Studies, Houston
Dermatology Research Associates, Los Angeles
Clinical Science Institute, Santa Monica
Huntington Medical Foundation/Specialty Office, Pasadena
California Dermatology & Clinical Research Institute, Encinitas
Dermatology Specialists, Inc., Oceanside
Clinical Pharmacology Study Group, Worcester
Dartmouth-Hitchcock Medical Center - Section of Dermatology, Lebanon
Clinical Partners, LLC, Johnston
Premier Clinical Research, Spokane
Enverus Medical Research, Surrey
Co-Medica Research Network Inc., Courtice
Lynderm Research Inc., Markham
Research by ICLS, Oakville
SKiN Centre for Dermatology, Peterborough
The Centre for Dermatology & Cosmetic, Richmond Hill
K.Papp Clinical Research Inc., Waterloo
Dr Isabelle Delorme Inc., Drummondville
Innovaderm Research Inc., Montreal
Q & T Research Sherbrooke Inc., Sherbrooke
Lead Sponsor
Pfizer
INDUSTRY